Nanoparticles enhance immune response against cancer in mice
phys.org — July 26, 2024, 02:00 PM UTC
Summary: Vanderbilt University researchers have created nanoparticles that enhance the immune response against melanoma and breast cancer in mice. Published in ACS Nano, the study focuses on lipid nanoparticles delivering a nucleic acid that activates the RIG-I pathway, typically used to combat viral infections. This approach shows promise for future human cancer treatments, building on the success of mRNA vaccines.
Article metrics
The article metrics are deprecated.
I'm replacing the original 8-factor scoring system with a new and improved one. It doesn't use the original factors and gives much better significance scores.